HCV infective virions can be carried by human platelets

Cell Biochemistry and Function

Volumn 22, Issue 6, 2004, Pages 353-358

  Pugliese, A ^a   Gennero, L ^a   Cutufia, M ^a   Enrietto, M ^a   Morra, E ^a   Pescarmona, P ^a   Ponzetto, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Fibronectin; HCV infection; Platelets; THP 1 cells

Indexed keywords

FIBRONECTIN; GLYCYLARGINYLGLYCYLASPARTYLSERYLPROLINE;

ARTICLE; BLOOD SAMPLING; CHRONIC ACTIVE HEPATITIS; DISEASE SEVERITY; FLOW CYTOMETRY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SUPERNATANT; TARGET CELL; THROMBOCYTE MEMBRANE; VIRION; VIRUS CARRIER; VIRUS INFECTION; VIRUS REPLICATION;

BLOOD PLATELETS; CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMANS; VIRION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 8744250951     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1113     Document Type: Article

References (20)

1. Pugliese A, Savarino A, Cantamessa C, Torre D. Influence of fibronectin on HIV-1 infection and capability of binding to platelets. Cell Biochem Funct 1996; 14: 291-296.
2. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzales J, Pedreira J. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999; 31(S1): 119-123.
3. Sulkowski MS. Hepatitis C virus infection in HIV-infected patients. Curr Infect Dis Rep 2001; 3: 469-476.
4. Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT. Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection. Am J Gastroenterol 2002; 97: 478-483.
5. Allain JP. Transfusion risks of yesterday and of today. Transfus Clin Biol 2003; 10: 1-5.
6. Hamaia S, Li C, Allain JP. The dynamics of hepatitis C virus binding to platelets and two mononuclear cell lines. Blood 2001; 98: 2293-2300.
7. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-176.
8. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385-2390.
9. Ruoslahti E. Fibronectin and its receptors. Ann Rev Biochem 1988; 57: 375-413.
10. Iacovacci S, Manzin A, Barca S, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997; 26: 1328-1337.
11. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
12. Burioni R, Plaisant P, Manzin A, et al. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998; 28: 810-814.
13. Burioni R, Bugli F, Mancini N, et al. Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology 2001; 288: 29-35.
14. Savarino A, Calosso L, Piragino A, et al. Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1. Cell Biochem Funct 1999; 17: 47-55.
15. Gratchev A, Guillot P, Hakiy N, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001; 53: 386-392.
16. Jacob SS, Shastry P, Sudhakaran PR. Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum. Mol Cell Biochem 2002; 233: 9-17.
17. Dourakis SP, Deutsch M, Hadziyannis SJ. Immune thrombocytopenia and alpha-interferon therapy. J Hepatol 1996; 25: 972-975.
18. Hernandez F, Blanquer A, Linares M, Lopez A, Tarin F, Cervero A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998; 99: 217-220.
19. Sansonno D, Lotesoriere C, Cornacchiulo V, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998; 92: 3328-3337.
20. Li X, Jeffer LJ, Garon C, Fischer ER, Scheffel J, Moore B, Reddy KR, Demedina M, Schiff ER. Persistence of hepatitis C virus in a human megakaryoblastic leukemia cell line. J Viral Hepat 1999; 6: 107-114.